Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZTS
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.80 3.33 3.36
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -9.30 5.17 5.70
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.44 11.04 10.89
Cash -3.02 4.31 4.45
Capex 29.14 -0.31 -0.43
Free Cash Flow -34.76 0.99 1.52
Revenue -0.82 4.78 4.82
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 5.38 0.69 0.65
Operating Margin 14.16 0.37 0.32
ROA 13.60 0.04 0.04
ROE 12.72 0.12 0.11
ROIC 12.28 0.06 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZTS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZTS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZTS is permitted for members.